Embecta (Nasdaq:EMBC) stock was down today after news of restructuring and mixed second-quarter results. Shares of EMBC were down more than 8% to $12.12 apiece near the close of trading today.

Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

Solventum, spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%.

The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 ...

SS Innovations plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system.

Enovis beat earnings expectations in its first quarter 2025 results out today, but the market reaction was tempered.

German medtech giant Siemens Healthineers reduced the lower end of its full-year earnings guidance amid Trump administration ...

Bausch + Lomb announced today that it received CE mark approval for its LuxLife full range of vision intraocular lens (IOL).

Boston Scientific (NYSE: BSX) + Boston Scientific Corp. $104.068 0.15% Open 104.222 Day High 104.79 52 Week High 79.43 52 ...

MicroTransponder has reported the results of a one-year follow-up study of its Vivistim Paired VNS System for chronic stroke ...

GE HealthCare (Nasdaq: GEHC) announced today that it received FDA 510(k) clearance for its Aurora nuclear medicine system and ...

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.